Drug Landscape ›
Ephedrine 5mg ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 10
Most-reported reactions
Acute Respiratory Distress Syndrome — 1 report (10%) Blood Loss Anaemia — 1 report (10%) Caesarean Section — 1 report (10%) Circumstance Or Information Capable Of Leading To Medication Error — 1 report (10%) Diplopia — 1 report (10%) Disseminated Intravascular Coagulation — 1 report (10%) Drug Hypersensitivity — 1 report (10%) Hepatic Function Abnormal — 1 report (10%) Hypoglycaemia — 1 report (10%) Lactic Acidosis — 1 report (10%)
Source database →
Ephedrine 5mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Ephedrine 5mg approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Ephedrine 5mg in United States?
Aswan University is the originator. The local marketing authorisation holder may differ — check the official source linked above.